SMN2 and proximal spinal muscular atrophy: Complete loss of SMN2 has no phenotypic effect in healthy individuals; however, in SMA patients, SMN2 is the primary genetic modifier of disease severity (Feldkötter et al., 2002; Lefebvre et al., 1997; Velasco et al., 1996).